GlassScriptPhysician profile
Sam M Serouya
NPI 1013208859
$10,062.50
in general payments reported to CMS, 2019-2025
17 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,015 · 2020: $3,258 · 2021: $968 · 2022: $1,519 · 2023: $632 · 2024: $263 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284 · Debt Forgiveness: $18.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.42 |
| Debt Forgiveness | $18.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu A/S | $3,514.75 | 2020-2022 | |
| Olympus Corporation of The Americas | $1,797.86 | 2019 | |
| Olympus America INC. | $1,328.26 | 2019-2025 | Single Use Repositionable Clip |
| Boston Scientific Corporation | $1,163.73 | 2019-2025 | Axios, Resolution Clip |
| Pinnacle Biologics, INC | $500.00 | 2022 | |
| Cook Medical LLC | $456.85 | 2019-2021 | |
| Conmed Corporation | $434.30 | 2019-2025 | Conmed Biliary |
| Ambu INC. | $300.00 | 2022 | |
| Pentax of America, INC. | $191.78 | 2023 | Aloka Arietta 850 |
| Micro-Tech Endoscopy USA, INC. | $116.54 | 2023 | Eyemax |
| Novo Nordisk INC | $94.18 | 2024 | Wegovy |
| Argenx US, INC. | $52.37 | 2022-2023 | Vyvgart |
| Fujifilm Healthcare Americas Corporation | $28.91 | 2025 | |
| Janssen Biotech, INC. | $26.70 | 2024 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.29 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.30 | 2025 | |
| Clovis Oncology, INC. | $17.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Serouya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.